MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),，我們不為任何個人用途提供產(chǎn)品和服務(wù),。

K-Ras-PDEδ-IN-1

產(chǎn)品活性：K-Ras-PDEδ-IN-1 是一種新穎的,、有效的 K-Ras-PDEδ 抑制劑,。K-Ras-PDEδ-IN-1 以低納摩爾 K_d 8 nM 與 PDEδ 的法尼基結(jié)合袋競爭性結(jié)合,。

研究領(lǐng)域：Metabolic Enzyme/Protease

作用靶點(diǎn)：Phosphodiesterase (PDE)

In Vitro: K-Ras-PDEδ-IN-1 exhibits an IC₅₀ value of 12.3 μM in PaTu8902/Panc1 CTG assay.

In Vivo: K-Ras-PDEδ-IN-1 (oral or intraperitoneal?injection; 10 mg/kg; single dose) is in different vehicles (A=5% Tween-80, 50% NaCl, 45% H2O; B=20% DMSO, 80% PEG200; C=15% DMSO, 9.5% Cremophor EL/EtOH (1:1), 75.5 % H2O) for oral and intraperitoneal (IP) administration.whereas only very low compound levels are found in plasma after oral dosage, but significantly higher plasma concentrations are found after IP administration in vehicle A, B or C at 10 mg kg.
K-Ras-PDEδ-IN-1 (intravenous?injection; 3 mg kg; single dose; 24 hours) shows a significant increase of the plasma exposure as well as the terminal half-life (t_1/2=0.4 hours)when compares to compound 93,exhibits a t_1/2, CO, AUC_0-tz, AUC_0.inf-obs, Cl_obs, and Vss_0-inf-obs values of 4.1 hours, 2790.9 ng/ml, 1646.4 h.ng/ml, 1662.5 h.ng/ml, 1.8 L/h/kg, 5.9 l/kg.

相關(guān)產(chǎn)品：Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Anti-Alzheimer's Disease Compound Library  |  Neurodegenerative Disease-related Compound Library  |  Anti-Colorectal Cancer Compound Library   |  Heterocyclic Compound Library  |  Cirsimarin  |  PDE11-IN-1  |  Enpp-1-IN-2  |  PAT-347  |  Vardenafil-d₅  |  Bay 60-7550  |  Deltarasin hydrochloride  |  HA155  |  Apremilast  |  Enpp-1-IN-6  |  Roflumilast  |  RS-25344 hydrochloride  |  PDE4-IN-6  |  Sp-cAMPS  |  ITI-214  |  Irsenontrine maleate  |  Lodenafil  |  Osoresnontrine  |  Deltasonamide 2  |  PF-07038124  |  Ziritaxestat  |  ATX inhibitor 22  |  Milrinone-d₃  |  Avanafil-¹³C,d₃  |  MT-3014  |  ATX inhibitor 19  |  Homo Sildenafil-d₅  |  Furamidine  |  PDE4-IN-12  |  Enpp-1-IN-8

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,，我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物；
•   50,000 多種高選擇性抑制劑,、激動劑涉及各熱門信號通路及疾病領(lǐng),；
•   產(chǎn)品種類涵蓋各種重組蛋白，多肽,，常用試劑盒 ,，更有 PROTAC、ADC 等特色產(chǎn)品,，廣泛應(yīng)用于新藥研發(fā),、生命科學(xué)等科研項(xiàng)目；
•   提供虛擬篩選,，離子通道篩選,，代謝組學(xué)分析檢測分析,，藥物篩選等專業(yè)技術(shù)服務(wù)；
•   設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控,、驗(yàn)證體系,；
•   提供 LC/MS、NMR,、HPLC,、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告,，確保產(chǎn)品的高純度,、高品質(zhì)；
•   產(chǎn)品的生物活性多經(jīng)各國客戶實(shí)驗(yàn)驗(yàn)證,；
•   Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果,；
•   專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展，為您提供*新的活性化合物,；
•   與世界各大制藥公司及著名科研機(jī)構(gòu)建立了長期的合作,。